Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021

Business Wire July 14, 2021

Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products

Business Wire June 30, 2021

Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing

Business Wire June 21, 2021

Eccogene announces the addition of Jacques Mizrahi, PhD to Scientific Advisory Board

PR Newswire June 17, 2021

Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC

PR Newswire June 17, 2021

Targovax announces completed enrollment in the phase 1/2 trial with ONCOS-102 in combination with durvalumab in patients with advanced colorectal cancer with peritoneal malignancies

PR Newswire June 17, 2021

iSpecimen Announces Pricing of Initial Public Offering

PR Newswire June 16, 2021

Fingerpaint Acquires Splice, Boosting the Company's West Coast Presence

PR Newswire June 16, 2021

Nature Journal Publishes Prospective, Randomized Study Validating Signatera® for Prediction of Immunotherapy Benefit

PR Newswire June 16, 2021

Swift Biosciences Meets NGS Demands by Offering 1536-Plex UDIs

PR Newswire June 16, 2021

Aruvant Partners with Aldevron to Provide Key Plasmid Raw Materials Used to Manufacture Pipeline Products

PR Newswire June 16, 2021

PlantArcBio announces collaboration agreement with Bioceres Crop Solutions to develop improved biomass & drought tolerant Alfalfa

PR Newswire June 16, 2021

LuminUltra named 2021 Company of the Year by Water Canada

Canada NewsWire June 16, 2021

Aequor Technologies Announces Acquisition of HireLifeScience.com

PR Newswire June 16, 2021

Debiopharm and Ubix Therapeutics Launch Research to Develop a New Anti-Cancer Modality - Antibody Degraducer® Conjugates

PR Newswire June 16, 2021

DarioHealth Expands Footprint in Musculoskeletal Sensor Technologies with the Upright GO S

PR Newswire June 16, 2021

Amyris to Present at the Jefferies Virtual Consumer Conference on June 23, 2021

PR Newswire June 16, 2021

Lipocine To Present At The Raymond James Human Health Innovation Conference

PR Newswire June 16, 2021

ViaCyte to Present at the Raymond James 2021 Human Health Innovation Conference

PR Newswire June 16, 2021

Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease

PR Newswire June 16, 2021